In sight of the major relevance of the antibody response to control parasitemia, a vaccine strategy that promotes a protective response against conserved regions of surface protein sequences may contribute to control AAT, especially if it is accompanied of CD4+ T cells inducing epitopes and the adjuvant used to exacerbate the exerted response biases it towards a Th1 profile. The gene discussed is PROS1; the disease is parasitic infectious disease.